Maybe the God of Hellfire, but NO WAY is he even close, except perhaps in his own mind.
Thirty three years have past since Wormser first published on Lyme disease. Since that time, with millions of tax-payers dollars (federal grants/NIH, CDC) he published 235 more times about the same things, over and over and over again.
While pumping out his useless papers he spent his spare time testifying against Lyme patients and doctors in legal cases and accepting monetary grants and perks from Lyme disease stake holders.
After being immersed in Lyme, Lyme, Lyme for over 12,000 days in a row he has had the ability, means and power to fix the Lyme "confusion" and obviously now realizes he has failed, so now he wants to change the name of an established medical illness with serious consequences because everyone else is "confused".
The key presumption is that serologic testing for antibodies to B. burgdorferi sensu lato is too insensitive to exclude B. burgdorferi infection despite weeks to months of symptoms. This perspective on Lyme disease/chronic Lyme disease has been widely endorsed by Lyme disease activists, support groups, and politicians. Consequently, there is increasing confusion about what Lyme disease is, or is not, for both patients and healthcare practitioners.
As scientific evidence is not persuasive in this matter, perhaps an approach that would enable clinicians and patients to better understand what was originally intended with the term Lyme disease, is to change the name of the illness using a name that conveys that the condition is not solely a clinical diagnosis, but instead a clinical and a microbiologic/laboratory diagnosis.
To this end, we propose the name B. burgdorferi sensu lato infection, or Bbsl infection for short, instead of Lyme disease. Since most patients with erythema migrans cannot be readily proven to have laboratory evidence of B. burgdorferi infection, such cases would be counted as possible Bbsl infection.
Microbiology taxonomists coincidently are arguing that Lyme borrelia should be referred to as Borreliella, reserving the term borrelia for relapsing fever type borrelia strains (e.g., B. hermsii). This change would be expected to cause even more confusion in the Lyme disease field and not benefit in any way clinicians, clinical microbiology laboratories, or patients. The name change proposed here, however, might be immensely helpful to patients and health care practitioners interested in evidence based medicine and thus should be a topic for future discussions.
Wormser & Wormser
"A 1922 report by Garin and Bujadoux is widely regarded as describing the first case of neurologic Lyme borreliosis. Although the patient reported had a tick bite followed by the development of a rash and radiculoneuritis, there were a number of highly atypical features, raising the question of whether the patient, in fact, had neurologic Lyme borreliosis. The paper may not deserve the historic recognition that it has received."
Did Garin and Bujadoux Actually Report a Case of Lyme Radiculoneuritis?
https://www.ncbi.nlm.nih.gov/pubmed/27419161
We could let Wormser have his "evidence based" name of B. burgdorferi sensu lato infection.
If Wormser gets his way, what would changing the name of Lyme disease mean? Or what would need to be done if the change was made?
What would we have to change?
Legislative bill wording nation wide.
Medical guidelines.
Federal grant applications and awards.
Book titles.
Lab test names and codes.
Codes established for Lyme disease with insurers.
Our groups & organizations names world wide.
Wormser & his buddies attack patients and the doctors that treat them because he is frustrated and confused himself.
Similar to other antiscience groups, these advocates have created a pseudoscientific and alternative selection of practitioners, research, and publications and have coordinated public protests, accused opponents of both corruption and conspiracy, and spurred legislative efforts to subvert evidence-based medicine and peer-reviewed science. The relations and actions of some activists, medical practitioners, and commercial bodies involved in Lyme disease advocacy pose a threat to public health.
Antiscience and ethical concerns associated with advocacy of Lyme disease.
Auwaerter PG1, Bakken JS, Dattwyler RJ, Dumler JS, Halperin JJ, McSweegan E, Nadelman RB, O'Connell S, Shapiro ED, Sood SK, Steere AC, Weinstein A, Wormser GP.
https://www.ncbi.nlm.nih.gov/pubmed/21867956
IDSA Lyme Guidelines- 10 times
The Clinical Assessment, Treatment, and Prevention of Lyme Disease, Human Granulocytic Anaplasmosis, and Babesiosis: Clinical Practice Guidelines by the Infectious Diseases Society of America
Gary P. Wormser,1 Raymond J. Dattwyler,2 Eugene D. Shapiro,5,6 John J. Halperin,3,4 Allen C. Steere,9
Mark S. Klempner,10 Peter J. Krause,8 Johan S. Bakken,11 Franc Strle,13 Gerold Stanek,14 Linda Bockenstedt,7Durland Fish,6 J. Stephen Dumler,12 and Robert B. Nadelman1
Wormser and his buddies even elude to the fact they are unsure of themselves, confusing others in the process.
We conclude that the clinical diagnosis of erythema migrans is highly accurate in an area where B. burgdorferi is endemic if it is made by experienced health care personnel, but some patients with this diagnosis may not have B. burgdorferi infection. No single diagnostic modality is suitable for detection of B. burgdorferi in every patient with erythema migrans.
Laboratory diagnostic techniques for patients with early Lyme disease associated with erythema migrans: a comparison of different techniques.
https://www.ncbi.nlm.nih.gov/pubmed/11700579
WORMSER
Lyme borreliosis
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5539539/
Unraveling Lyme Disease
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4282157/
Metabolic differentiation of early Lyme disease from southern tick–associated rash illness (STARI)
http://stm.sciencemag.org/content/9/403/eaal2717
Diagnosis of Lyme Borreliosis
http://cmr.asm.org/content/18/3/484.full
Development of a Metabolic Biosignature for Detection of Early Lyme Disease
https://academic.oup.com/cid/article/60/12/1767/2462619
Failure of treatment with cephalexin for Lyme disease.
https://www.ncbi.nlm.nih.gov/pubmed/10862221
The clinical spectrum of early Lyme borreliosis in patients with culture-confirmed erythema migrans.
https://www.ncbi.nlm.nih.gov/pubmed/8644761
CDC is using "confused"
Concerns Regarding a New Culture Method for Borrelia burgdorferi Not Approved for the Diagnosis of Lyme Disease
https://www.cdc.gov/mmwr/preview/mmwrhtml/mm6315a4.htm
Halperin is using "confused"
Nervous system Lyme borreliosis--revisited [corrected; erratum to be published].
https://www.ncbi.nlm.nih.gov/pubmed/1728254
Neuroactive kynurenines in Lyme borreliosis. 1992
https://www.ncbi.nlm.nih.gov/pubmed/1531156
https://books.google.com/books?id=ajh4a8kjoeAC&pg=PA161&lpg=PA161&dq=wormser+%22confused%22+Lyme&source=bl&ots=iiegpLl3Mj&sig=cJteYEEnOByoGaRzDPyOkqIaOYc&hl=en&sa=X&ved=0ahUKEwiQq6Hvx6XcAhVP7FMKHc2bAdU4ChDoAQhYMAk#v=onepage&q=wormser%20%22confused%22%20Lyme&f=false
Auwaerter uses "confused"
Lyme Disease: Knowing Good Evidence to Help Inform Practice
What Clinicians Should Know About the New Lyme Species
https://www.id.theclinics.com/article/S0891-5520(15)00031-8/fulltext
Chronic Lyme disease diagnosis causes rift
https://whyy.org/articles/chronic-lyme-disease-diagnosis-causes-rift/
Auwaerter uses bigger words cause he is from Hopkins
It is not possible to draw firm conclusions on the relative efficacy of accepted antibiotic drug regimens for the treatment of LNB.
Antibiotics for the neurological complications of Lyme disease.
https://www.ncbi.nlm.nih.gov/pubmed/27931077
Dattwyler
Commentary On The treatment Of Early Lyme Disease
https://academic.oup.com/cid/article/50/4/521/352005
Positive Lyme serology in subacute bacterial endocarditis. A study of four patients.
https://www.ncbi.nlm.nih.gov/pubmed/2232087
Treatment of Lyme Disease Spurs Fierce Debate
http://articles.courant.com/1997-07-14/news/9707140021_1_lyme-heart-disease-chronic/3
Lantos
Chronic Lyme Disease- 13 times referred to confusion
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4477530/
Dumler
Is human granulocytic ehrlichiosis a new Lyme disease? Review and comparison of clinical, laboratory, epidemiological, and some biological features.
https://www.ncbi.nlm.nih.gov/pubmed/9233663
Sigal
The Lyme disease controversy. Social and financial costs of misdiagnosis and mismanagement.
https://www.ncbi.nlm.nih.gov/pubmed/8687256
Contributions of societal and geographical environments to "chronic Lymedisease": the psychopathogenesis and aporology of a new "medically unexplained symptoms" syndrome.
https://www.ncbi.nlm.nih.gov/pubmed/12194894
Misconceptions about Lyme disease: confusions hiding behind ill-chosen terminology. Sigal
Look up link
Steere
Current Understanding of Lyme Disease
https://www.ncbi.nlm.nih.gov/pubmed/8463365
Neurological Findings of Lyme Disease (1984)
https://www.ncbi.nlm.nih.gov/pubmed/6516450
Krause
Babesiosis in a renal transplant recipient acquired through blood transfusion. (CO-INFECTION Confusion) 2000
https://www.ncbi.nlm.nih.gov/pubmed/10919602
Nowakowski
Failure of treatment with cephalexin for Lyme disease.
https://www.ncbi.nlm.nih.gov/pubmed/10862221
The clinical spectrum of early Lyme borreliosis in patients with culture-confirmed erythema migrans.
https://www.ncbi.nlm.nih.gov/pubmed/8644761
Nadelman
The clinical spectrum of early Lyme borreliosis in patients with culture-confirmed erythema migrans.
https://www.ncbi.nlm.nih.gov/pubmed/8644761
Pachner
Neurologic manifestations of Lyme disease, the new "great imitator"
https://www.ncbi.nlm.nih.gov/pubmed/2682960
Neurological Findings of Lyme Disease (1984)
https://www.ncbi.nlm.nih.gov/pubmed/6516450
Metabolic differentiation of early Lyme disease from southern tick-associated rash illness (STARI).
Molins CR, Ashton LV, Wormser GP, Andre BG, Hess AM, Delorey MJ, Pilgard MA, Johnson BJ, Webb K, Islam MN, Pegalajar-Jurado A, Molla I, Jewett MW, Belisle JT.
Sci Transl Med. 2017 Aug 16;9(403). pii: eaal2717. doi: 10.1126/scitranslmed.aal2717.
PMID:
28814545
Select item 108622212.
Failure of treatment with cephalexin for Lyme disease.
Nowakowski J, McKenna D, Nadelman RB, Cooper D, Bittker S, Holmgren D, Pavia C, Johnson RC, Wormser GP.
Arch Fam Med. 2000 Jun;9(6):563-7.
PMID:
10862221
Select item 86447613.
The clinical spectrum of early Lyme borreliosis in patients with culture-confirmed erythema migrans.
Nadelman RB, Nowakowski J, Forseter G, Goldberg NS, Bittker S, Cooper D, Aguero-Rosenfeld M, Wormser GP.
Am J Med. 1996 May;100(5):502-8.
PMID:
8644761
Select item 29160944.
Quentzel HL, Nadelman RB, Ng J, Wormser GP.
Rev Infect Dis. 1989 Jan-Feb;11(1):122-7.
PMID:
2916094
Lucy Barnes